- Table of Contents
The World Health Organization has declared COVID-19 as a pandemic. As COVID-19 spreads globally, communities are taking containment and mitigation steps while researchers are working hard to develop effective vaccines and treatments.
A recent research paper published in the journal Cell investigates how SARS-CoV-2, the virus that causes COVID-19, infects target cells through the interaction of its protein spike with the angiotensin-converting enzyme 2 (ACE2) receptor. In the paper, Pöhlmann and his colleagues also discuss that SARS-CoV-2's protein spike is primed by the enzyme TMPRSS2. Furthermore, their research suggests that antibodies against SARS-CoV spike could hinder the ability of SARS-CoV-2 to infect cells.
We've also prepared an infographic for you that provides concise information about the coronavirus, transmission, symptoms, protection advice, and vaccines and treatments undergoing development.See the infographic
Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.Troubleshooting guides
Get better results with Boster!
Boster takes great measures to ensure product quality and to provide our customers with comprehensive data upfront. Our antibodies are validated using WB, IHC, and flow cytometry against a panel of over 250 tissues and un-transfected cell lines to ensure high affinity and crystal-clear IHC stains. In addition, we also validate our antibodies in a quantitative fashion by testing them on known quantities of recombinant proteins so that you know what to expect (e.g. if there is 1ng, 2.5ng or 5ng of the target protein in the sample). Every product is covered by the Boster Quality Guarantee. Click below to learn more.
Have questions? We're here to help.